● Recruiting

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

Condition: Relapsed Multiple Myeloma · Refractory Multiple Myeloma · Sponsor: Opna Bio LLC

PhasePhase 1

Planned participants130

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

Phase 1b, open-label study evaluating the safety, tolerability, pharmacokinetics, preliminary antitumor activity, and pharmacodynamics of OPN-6602 monotherapy and in combination with dexamethasone in subjects with relapsed and/or refractory MM.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (12)

Banner MD Anderson	Gilbert, Arizona, United States	Recruiting
UC San Diego Moores Cancer Center	La Jolla, California, United States	Recruiting
Stanford Cancer Institute	Stanford, California, United States	Recruiting
Emory Winchip Cancer Center	Atlanta, Georgia, United States	Recruiting
University of Kansas Clinical Research Center	Westwood, Kansas, United States	Recruiting
Dana Farber Cancer Institute	Boston, Massachusetts, United States	Recruiting
Karmanos Cancer Institute	Detroit, Michigan, United States	Recruiting
START Midwest	Grand Rapids, Michigan, United States	Recruiting
University of Rochester Medical Center	Rochester, New York, United States	Recruiting
University of North Carolina Hospitals at Hillsborough	Chapel Hill, North Carolina, United States	Recruiting
Huntsman Cancer Center Institute University of Utah	Salt Lake City, Utah, United States	Recruiting
Fred Hutchinson Cancer Center	Seattle, Washington, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06433947